MDI-2517

· MDI Therapeutics, Inc.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for MDI-2517, covering 2025-03-14 to 2025-10-24. Get the full timeline:

Most recent: Clinical Trial Update: Single Ascending Dose and Multiple Ascending Dose Evaluation of Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of MDI-2517 in Healthy Participants [Phase 1]

See pricing